Heart matters: new treatments, tools and access channels
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Nature Biotechnology, published online: November 19, 2025; doi:10.1038/s41587-025-02933-0
The biopharmaceutical company’s renewed interest in cardiovascular disease is expanding to new targets and modalities, with more practical formulations to improve access and compliance.
